Orthocell Limited (OCC.AX)
AUD 1.58
(-1.25%)
AUD 1.58
(-1.25%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 | 1.17 Million AUD | 13.78% |
| 2023 | 1.03 Million AUD | 68.54% |
| 2022 | 613.57 Thousand AUD | 30.86% |
| 2021 | 468.88 Thousand AUD | 886.05% |
| 2020 | 47.55 Thousand AUD | -12.96% |
| 2019 | 54.63 Thousand AUD | 1.51% |
| 2018 | 53.81 Thousand AUD | -39.12% |
| 2017 | 88.39 Thousand AUD | -34.11% |
| 2016 | 134.16 Thousand AUD | -10.95% |
| 2015 | 150.66 Thousand AUD | -0.79% |
| 2014 | 151.87 Thousand AUD | -17.92% |
| 2013 | 185.02 Thousand AUD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 FY | 1.17 Million AUD | 13.78% |
| 2024 Q2 | 1.1 Million AUD | 0.0% |
| 2024 Q4 | 1.17 Million AUD | 0.0% |
| 2023 FY | 1.03 Million AUD | 68.54% |
| 2023 Q4 | 1.03 Million AUD | 0.0% |
| 2023 Q2 | 741.66 Thousand AUD | 0.0% |
| 2022 Q2 | 457.7 Thousand AUD | 0.0% |
| 2022 FY | 613.57 Thousand AUD | 30.86% |
| 2022 Q4 | 613.57 Thousand AUD | 0.0% |
| 2021 Q4 | 468.88 Thousand AUD | 0.0% |
| 2021 Q2 | 34.09 Thousand AUD | 0.0% |
| 2021 FY | 468.88 Thousand AUD | 886.05% |
| 2020 Q2 | 53.61 Thousand AUD | 0.0% |
| 2020 Q4 | 47.55 Thousand AUD | 0.0% |
| 2020 FY | 47.55 Thousand AUD | -12.96% |
| 2019 Q4 | 54.63 Thousand AUD | 0.0% |
| 2019 Q2 | 45.3 Thousand AUD | 0.0% |
| 2019 FY | 54.63 Thousand AUD | 1.51% |
| 2018 Q4 | 53.81 Thousand AUD | 0.0% |
| 2018 FY | 53.81 Thousand AUD | -39.12% |
| 2018 Q2 | 87.43 Thousand AUD | 0.0% |
| 2017 FY | 88.39 Thousand AUD | -34.11% |
| 2017 Q4 | 88.39 Thousand AUD | 0.0% |
| 2017 Q2 | 105.06 Thousand AUD | 0.0% |
| 2016 Q2 | 129.26 Thousand AUD | 0.0% |
| 2016 FY | 134.16 Thousand AUD | -10.95% |
| 2016 Q4 | 134.16 Thousand AUD | 0.0% |
| 2015 Q4 | 150.66 Thousand AUD | 0.0% |
| 2015 Q2 | 171.91 Thousand AUD | 0.0% |
| 2015 FY | 150.66 Thousand AUD | -0.79% |
| 2014 FY | 151.87 Thousand AUD | -17.92% |
| 2014 Q4 | 151.87 Thousand AUD | 0.0% |
| 2014 Q2 | 176.59 Thousand AUD | 0.0% |
| 2013 Q4 | 185.02 Thousand AUD | 0.0% |
| 2013 Q3 | 185.02 Thousand AUD | 0.0% |
| 2013 FY | 185.02 Thousand AUD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| AdAlta Limited | -1.67 Million AUD | 170.058% |
| Acrux Limited | 147 Thousand AUD | -700.434% |
| Amplia Therapeutics Limited | - AUD | -Infinity% |
| Biome Australia Limited | 1.88 Million AUD | 37.697% |
| BTC Health Limited | - AUD | -Infinity% |
| Chimeric Therapeutics Limited | - AUD | -Infinity% |
| CSL Limited | 8.93 Billion AUD | 99.987% |
| Clarity Pharmaceuticals Ltd | - AUD | -Infinity% |
| Clinuvel Pharmaceuticals Limited | 10.62 Million AUD | 88.927% |
| Noxopharm Limited | -2.35 Million AUD | 149.874% |
| PharmAust Limited | - AUD | -Infinity% |
| Proteomics International Laboratories Limited | - AUD | -Infinity% |
| Prescient Therapeutics Limited | - AUD | -Infinity% |
| PYC Therapeutics Limited | -17.99 Million AUD | 106.538% |
| Race Oncology Limited | 16.4 Thousand AUD | -7074.185% |
| Starpharma Holdings Limited | 2.4 Million AUD | 51.136% |
| EZZ Life Science Holdings Limited | 1.4 Million AUD | 16.026% |
| Botanix Pharmaceuticals Limited | 1.2 Million AUD | 2.707% |
| Memphasys Limited | 164.76 Thousand AUD | -614.148% |
| Nyrada Inc. | - AUD | -Infinity% |
| Anatara Lifesciences Ltd | -671.09 Thousand AUD | 275.332% |
| Telix Pharmaceuticals Limited | 17.31 Million AUD | 93.203% |
| Bio-Gene Technology Limited | - AUD | -Infinity% |
| Zelira Therapeutics Limited | 1.25 Million AUD | 6.043% |
| Patrys Limited | - AUD | -Infinity% |
| Dimerix Limited | - AUD | -Infinity% |
| Neuren Pharmaceuticals Limited | - AUD | -Infinity% |
| Imugene Limited | - AUD | -Infinity% |
| Cynata Therapeutics Limited | 108.2 Thousand AUD | -987.426% |
| Immutep Limited | 2.00 AUD | -58831800.0% |
| Arovella Therapeutics Limited | - AUD | -Infinity% |
| Alterity Therapeutics Limited | 1.00 AUD | -117663700.0% |
| Nanollose Limited | - AUD | -Infinity% |
| Invex Therapeutics Ltd | -94.98 Thousand AUD | 1338.788% |
| NeuroScientific Biopharmaceuticals Limited | - AUD | -Infinity% |
| Island Pharmaceuticals Limited | -877.24 Thousand AUD | 234.13% |
| Biotron Limited | - AUD | -Infinity% |
| Radiopharm Theranostics Limited | -987.41 Thousand AUD | 219.164% |
| Tissue Repair Ltd | 214.72 Thousand AUD | -447.982% |
| AnteoTech Limited | 221.85 Thousand AUD | -430.359% |
| Hexima Limited | - AUD | -Infinity% |
| Paradigm Biopharmaceuticals Limited | - AUD | -Infinity% |
| Recce Pharmaceuticals Ltd | - AUD | -Infinity% |
| Avecho Biotechnology Limited | 97.11 Thousand AUD | -1111.567% |
| Actinogen Medical Limited | 108.82 Thousand AUD | -981.181% |
| Immuron Limited | 1.58 Million AUD | 25.746% |
| Argenica Therapeutics Limited | - AUD | -Infinity% |